Evidence map›Paper›PMID 35217662›Full record

ArticleSchizophrenia (Heidelberg, Germany)2022

Deep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: Proof-of-concept study.

Scott J Moeller, Roberto Gil, Jodi J Weinstein, Topaz Baumvoll, Kenneth Wengler, Natalka Fallon, Jared X Van Snellenberg, Sameera Abeykoon, Greg Perlman, John Williams and 5 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05724810 (Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05724810 naterminatednot on this mapstarted 2023, after this paper: background citation

Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia

TypeinterventionalSponsorStony Brook UniversityRan2023 to 2025Enrolled13ConditionsSchizophrenia, Smoking Cessation, Tobacco UseArmsActive deep transcranial magnetic stimulation (dTMS), Sham dTMS
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  5. Repetitive transcranial magnetic stimulation for smoking cessation.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Scott J MoellerRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA. scott.moeller@stonybrookmedicine.edu.ORCID http://orcid.org/0000-0002-4449-0844
Roberto GilRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Jodi J WeinsteinRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0002-0396-3596
Topaz BaumvollRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Kenneth WenglerRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0002-8153-5183
Natalka FallonRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Jared X Van SnellenbergRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0003-2442-2008
Sameera AbeykoonRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Greg PerlmanRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
John WilliamsRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0002-3500-914X
Lucian ManuRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Mark SlifsteinRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Clifford M CassidyUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa, ON, K1Z 8N3, Canada.
Diana M MartinezColumbia University, New York State Psychiatric Institute, New York, NY, 10032, USA.
Anissa Abi-DarghamRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA. anissa.abi-dargham@stonybrookmedicine.edu.ORCID http://orcid.org/0000-0002-5039-5069
Stony Brook School · USNew York State Psychiatric InstituteUniversity of Ottawa · CA

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008444 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 1992 to 2024
$12.6M
Towards an Integrated Understanding of Neurotransmitter Dysfunction in Schizophrenia: a Multimodal MRI StudyK23MH115291 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI WEINSTEIN, JODI JAY · 2018 to 2024
$1.2M
Translational Neuroscience of Functional Connectivity in SchizophreniaK01MH107763 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI VAN SNELLENBERG, JARED XAVIER · 2015 to 2019
$961k
Genetic markers associated with brain structural abnormalities and drug use in human addictionK01DA037452 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI MOELLER, SCOTT J · 2015 to 2019
$778k
Deep rTMS of the insula for smoking cessation in schizophreniaR21DA041128 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI ABI-DARGHAM, ANISSA · 2016 to 2017
$452k
Cholinergic transmission abnormalities associated with smoking behavior in humansR21DA051179 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI MOELLER, SCOTT J · 2020 to 2021
$439k
Mechanisms of impaired subcortical auditory processing in schizophreniaF30MH122136 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI WILLIAMS, JOHN CONNOR · 2019 to 2022
$180k
NIDA NIH HHS K01 DA037452NIDA NIH HHS R21 DA041128NIDA NIH HHS R21 DA051179NIGMS NIH HHS T32 GM008444NIMH NIH HHS F30 MH122136NIMH NIH HHS K01 MH107763NIMH NIH HHS K23 MH115291U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) F30MH122136U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) K01MH107763U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) K23MH115291U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) K01DA037452U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R21DA041128U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R21DA051179
6 · The paper itself

Abstract

Patients with schizophrenia have a high prevalence of cigarette smoking and respond poorly to conventional treatments, highlighting the need for new therapies. We conducted a mechanistic, proof-of-concept study using bilateral deep repetitive transcranial magnetic stimulation (dTMS) of insular and prefrontal cortices at high frequency, using the specialized H4 coil. Feasibility of dTMS was tested for disruption of tobacco self-administration, insula target engagement, and insula circuit modulation, all of which were a priori outcomes of interest. Twenty patients completed the study, consisting of weekday dTMS sessions (randomization to active dTMS or sham; double-blind; 10 patients per group), a laboratory tobacco self-administration paradigm (pre/post assessments), and multimodal imaging (three MRI total sessions). Results showed that participants assigned to active dTMS were slower to initiate smoking their first cigarette compared with sham, consistent with smoking disruption. The imaging analyses did not reveal significant Time × Group interactions, but effects were in the anticipated directions. In arterial spin labeling analyses testing for target engagement, an overall decrease in insula blood flow, measured during a post-treatment MRI versus baseline, was numerically more pronounced in the active dTMS group than sham. In fMRI analyses, resting-state connectivity between the insula and default mode network showed a numerically greater change from baseline in the active dTMS group than sham, consistent with a functional change to insula circuits. Exploratory analyses further suggested a therapeutic effect of dTMS on symptoms of psychosis. These initial observations pave the way for future confirmatory studies of dTMS in smoking patients with schizophrenia.

Identifiers

PMID35217662
PMCPMC8881463
OpenAlexW4214612812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.